Home
  • E-mailanne.stavelin@uib.no
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Aggregated data from the same laboratories participating in two glucose external quality assessment schemes show that commutability and transfers of values to control materials are decisive for the biases found. Clinical Chemistry and Laboratory Medicine.
  • Show author(s) (2022). Using three external quality assurance schemes to achieve equivalent international normalized ratio results in primary and secondary healthcare. Clinical Chemistry and Laboratory Medicine. 419-426.
  • Show author(s) (2022). Point-of-care testing in primary healthcare: a scoring system to determine the frequency of performing internal quality control. Clinical Chemistry and Laboratory Medicine. 740-747.
  • Show author(s) (2022). A national surveillance program for evaluating new reagent lots in medical laboratories. Clinical Chemistry and Laboratory Medicine. 351-360.
  • Show author(s) (2021). Feasibility for aggregation of commutable external quality assessment results to evaluate metrological traceability and agreement among results. Clinical Chemistry and Laboratory Medicine. 117-125.
  • Show author(s) (2020). Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data. Clinical Chemistry and Laboratory Medicine. 588-596.
  • Show author(s) (2020). Harmonising EQA schemes the next frontier: Challenging the status quo. Clinical Chemistry and Laboratory Medicine. 1795-1797.
  • Show author(s) (2019). Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM). Clinical Chemistry and Laboratory Medicine. 1511-1521.
  • Show author(s) (2019). Commutability of a whole-blood external quality assessment material for point-of-care C-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 791-797.
  • Show author(s) (2018). Harmonization activities of Noklus - A quality improvement organization for point-of-care laboratory examinations. Clinical Chemistry and Laboratory Medicine. 106-114.
  • Show author(s) (2017). Analytical performance specifications for external quality assessment - Definitions and descriptions. Clinical Chemistry and Laboratory Medicine. 949-955.
  • Show author(s) (2016). The importance of reagent lot registration in external quality assurance/proficiency testing schemes. Clinical Chemistry. 708-715.
  • Show author(s) (2016). Effect of participating in a quality improvement system over time for point-of-care c-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 1474-1481.
  • Show author(s) (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 849-853.
  • Show author(s) (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
  • Show author(s) (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
  • Show author(s) (2012). The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients. Scandinavian Journal of Clinical and Laboratory Investigation. 374-379.
  • Show author(s) (2012). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clinical Chemistry and Laboratory Medicine. 81-88.
  • Show author(s) (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
  • Show author(s) (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 1618-1626.
  • Show author(s) (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
  • Show author(s) (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-349.
Reader opinion piece
  • Show author(s) (2007). Response to Kitchen et al.'s external quality assessment of prothrombin time: The split-sample model compared to external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 676-677.
Short communication
  • Show author(s) (2005). Analyse av protrombintid i primærhelsetjenesten. Tidsskrift for Den norske legeforening. 2048-2049.
Feature article
  • Show author(s) (2017). Bioingeniører må forske på eget fag :. Bioingeniøren. 22-23.
Letter to the editor
  • Show author(s) (2017). Effect of dabigatran treatment at therapeutic levels on point-of-care international normalized ratio (INR). Clinical Chemistry and Laboratory Medicine. e143-e145.
Doctoral dissertation
  • Show author(s) (2013). Analytical quality control of INR measurements in primary care.
Abstract
  • Show author(s) (2013). Pre-analytical routines in coagulation testing: are guidelines followed? Journal of Thrombosis and Haemostasis. 18-18.
  • Show author(s) (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
Academic literature review
  • Show author(s) (2023). Analytical performance specifications and quality assurance of point-of-care testing in primary healthcare. Critical reviews in clinical laboratory sciences.
  • Show author(s) (2017). Essential aspects of external quality assurance for point-of-care testing. Biochemia Medica. 81-85.
  • Show author(s) (2017). An overview of the European organization for external quality assurance providers in laboratory medicine (EQALM). Biochemia Medica. 30-36.

More information in national current research information system (CRIStin)